drugset / Trial / NCT01454778

Effects of Paclitaxel on Intimal Hyperplasia

NCT01454778

Completed 50 enrolled Sanford Health
NaSingle-groupOpen-labelPrevention

Summary

This is a single, one time, limited dose infusion of Paclitaxel, that will potentially prevent recurrent stenosis secondary to intimal hyperplasia when compared to the control group at 10 months.

Timeline

Start
2011-04
Primary completion
2014-10
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 1.4 mg
Subject Paclitaxel Small molecule 1.8 mg
Subject Paclitaxel Small molecule 2.4 mg